Parliamentary Chair Rejects Palantir Claims of Ideological Bias in NHS Data Contract Controversy

UK lawmaker Chi Onwurah has rejected Palantir’s suggestion that criticism of its NHS England contract is driven by ideology, as the government reviews options to end the agreement for the Federated Data Platform (FDP). Onwurah chairs the Science, Innovation and Technology Select Committee, which is examining the digital transformation of government and public services, including the role of artificial intelligence.

The contract at the centre of the dispute is valued at £330 million and covers the FDP, described as an AI-driven system designed to bring together health information across the National Health Service. Officials are currently considering how to terminate the deal, including whether and how to use a break clause contained in the existing agreement.

Onwurah said it is appropriate for the government to seek advice on the practical steps required to trigger that break clause. She also pointed to her committee’s ongoing inquiry, which is expected to publish findings in the coming months as it assesses how technology is being used to modernise public services.

Concerns raised about the FDP contract include transparency around the agreement, the risk of vendor lock-in, and whether the arrangement offers value for money. Data security has also been cited as a key issue, particularly in relation to the use of patient information and the possibility that public confidence in the NHS could be weakened.

Palantir has pushed back on the criticism. Louis Mosley, the company’s UK executive vice-chair, previously warned the government against giving weight to what he described as “ideologically motivated campaigners” in connection with the contract.

The debate also sits within a broader picture of Palantir’s footprint in the UK public sector. In addition to its work with NHS England, the company has contracts with the Ministry of Defence, a number of police forces, and the United Kingdom’s financial regulatory body.

For markets and policymakers, the dispute highlights how large public-sector technology contracts can become politically sensitive when they involve centralised data systems and AI-linked tools. The government’s review of termination options, alongside parliamentary scrutiny, underscores the operational and reputational stakes for suppliers working with critical national institutions.

Key uncertainties remain, including what legal route the government may pursue to end the agreement and how any decision could affect timelines for the FDP’s intended consolidation of NHS data. The select committee’s forthcoming report is also expected to add detail to the public debate, but its conclusions have not yet been published.